Research ExplorerPublicationsInterventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil ...

Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry

Standard

Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. / Haas, Nikolaus A; Kock, Laura; Bertram, Harald; Boekenkamp, Regina; De Wolf, Daniel; Ditkivskyy, Igor; Freund, Matthias W; Gewillig, Marc; Happel, Christoph M; Herberg, Ulrike; Karthasyan, Edvard; Kozlik-Feldmann, Rainer; Kretschmar, Oliver; Kuzmenko, Yulia; Milanesi, Ornella; Mueller, Goetz; Pongiglione, Giacomo; Schubert, Stephan; Tarusinov, Gleb; Kampmann, Christoph.

In: PEDIATR CARDIOL, Vol. 38, No. 2, 02.2017, p. 215-227.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Haas, NA, Kock, L, Bertram, H, Boekenkamp, R, De Wolf, D, Ditkivskyy, I, Freund, MW, Gewillig, M, Happel, CM, Herberg, U, Karthasyan, E, Kozlik-Feldmann, R, Kretschmar, O, Kuzmenko, Y, Milanesi, O, Mueller, G, Pongiglione, G, Schubert, S, Tarusinov, G & Kampmann, C 2017, 'Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry', PEDIATR CARDIOL, vol. 38, no. 2, pp. 215-227. https://doi.org/10.1007/s00246-016-1502-8

APA

Haas, N. A., Kock, L., Bertram, H., Boekenkamp, R., De Wolf, D., Ditkivskyy, I., Freund, M. W., Gewillig, M., Happel, C. M., Herberg, U., Karthasyan, E., Kozlik-Feldmann, R., Kretschmar, O., Kuzmenko, Y., Milanesi, O., Mueller, G., Pongiglione, G., Schubert, S., Tarusinov, G., & Kampmann, C. (2017). Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. PEDIATR CARDIOL, 38(2), 215-227. https://doi.org/10.1007/s00246-016-1502-8

Vancouver

Haas NA, Kock L, Bertram H, Boekenkamp R, De Wolf D, Ditkivskyy I et al. Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. PEDIATR CARDIOL. 2017 Feb;38(2):215-227. https://doi.org/10.1007/s00246-016-1502-8

Bibtex

@article{440b72caec8540e1b05039558a8d127d,
title = "Interventional VSD-Closure with the Nit-Occlud{\textregistered} L{\^e} VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry",
abstract = "In August 2010, the Nit-Occlud{\textregistered} L{\^e} (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud{\textregistered} L{\^e}-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud{\textregistered} L{\^e} VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.",
keywords = "Adolescent, Cardiac Catheterization/methods, Child, Child, Preschool, Europe, Female, Fluoroscopy, Heart Septal Defects, Ventricular/classification, Hemolysis, Humans, Infant, Male, Operative Time, Registries, Retrospective Studies, Septal Occluder Device, Treatment Outcome",
author = "Haas, {Nikolaus A} and Laura Kock and Harald Bertram and Regina Boekenkamp and {De Wolf}, Daniel and Igor Ditkivskyy and Freund, {Matthias W} and Marc Gewillig and Happel, {Christoph M} and Ulrike Herberg and Edvard Karthasyan and Rainer Kozlik-Feldmann and Oliver Kretschmar and Yulia Kuzmenko and Ornella Milanesi and Goetz Mueller and Giacomo Pongiglione and Stephan Schubert and Gleb Tarusinov and Christoph Kampmann",
year = "2017",
month = feb,
doi = "10.1007/s00246-016-1502-8",
language = "English",
volume = "38",
pages = "215--227",
journal = "PEDIATR CARDIOL",
issn = "0172-0643",
publisher = "Springer New York",
number = "2",

}

RIS

TY - JOUR

T1 - Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry

AU - Haas, Nikolaus A

AU - Kock, Laura

AU - Bertram, Harald

AU - Boekenkamp, Regina

AU - De Wolf, Daniel

AU - Ditkivskyy, Igor

AU - Freund, Matthias W

AU - Gewillig, Marc

AU - Happel, Christoph M

AU - Herberg, Ulrike

AU - Karthasyan, Edvard

AU - Kozlik-Feldmann, Rainer

AU - Kretschmar, Oliver

AU - Kuzmenko, Yulia

AU - Milanesi, Ornella

AU - Mueller, Goetz

AU - Pongiglione, Giacomo

AU - Schubert, Stephan

AU - Tarusinov, Gleb

AU - Kampmann, Christoph

PY - 2017/2

Y1 - 2017/2

N2 - In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.

AB - In August 2010, the Nit-Occlud® Lê (EUREVECO) became available for transcatheter coil occlusion of ventricular septal defects (VSDs). Retrospective European Registry for VSD Closure using the Nit-Occlud® Lê-VSD-Coil; analysis of the feasibility, results, safety and follow-up of VSD-closure over a 3-year period in 18 European centers. In 102 of 111 patients (female 66), successful VSD closure was performed (mean age 8.2 years, mean weight 28.82 kg), 81 perimembranous VSDs (48 with aneurysm), 30 muscular VSDs, mean procedure time was 121.1 min, and mean fluoroscopy time was 26.3 min. Short- and midterm term follow-up was possible in 100/102 patients, there was 1 embolization and 1 explantation after 24 months. Immediate complete closure occurred in 49 of 101 patients (48.5%), trivial residual shunt was present in 51 (50.0%), closure rate was 95% after 6 months and 97% after 1 year. Out of the 102 patients, there were 2 severe complications (1.8%) (1 severe hemolysis, 1 embolization) and 8 moderate/transient (=7.2%) including 1 transient AV block. During a mean follow-up period of 31.3 months (range 24-48) and a total follow-up time of 224.75 patient years, no further problems occurred. VSD closure with the Nit-Occlud® Lê VSD coil is feasible and safe with a minimal risk of severe side effects. The long-term effects and safety require further clinical follow-up studies.

KW - Adolescent

KW - Cardiac Catheterization/methods

KW - Child

KW - Child, Preschool

KW - Europe

KW - Female

KW - Fluoroscopy

KW - Heart Septal Defects, Ventricular/classification

KW - Hemolysis

KW - Humans

KW - Infant

KW - Male

KW - Operative Time

KW - Registries

KW - Retrospective Studies

KW - Septal Occluder Device

KW - Treatment Outcome

U2 - 10.1007/s00246-016-1502-8

DO - 10.1007/s00246-016-1502-8

M3 - SCORING: Journal article

C2 - 27847970

VL - 38

SP - 215

EP - 227

JO - PEDIATR CARDIOL

JF - PEDIATR CARDIOL

SN - 0172-0643

IS - 2

ER -